| Striving to find the cause—and
the cure.
At Tomorrows Children’s Fund, our ultimate
dream is to provide a total cure for all children with cancer and
serious blood disorders. And because this goal can only be reached
through a greater understanding of the cause and treatment of these
diseases, one of our highest priorities is to support ongoing clinical
and laboratory research.
To this end, Tomorrows Children’s Fund was instrumental in
the January 2002 opening of the David Joseph Jurist Research Center
at Hackensack University Medical Center; a five story, 55,000 square
foot facility that gives investigators all the state-of-the-art laboratories
and technology required for groundbreaking scientific discovery under
one roof. Named for Mr. David Jurist, who is widely recognized for
his commitment to children and Co-
President of Tomorrows Children’s Fund, this premier institution houses
a state-of-the-art center for clinical research, as well as world-class laboratories
for:
Here, physicians and scientists from around the globe work together
to glean new insights into cancer and serious blood disorders and
find the advanced treatments that will stop them in their tracks.
For example, active clinical research and laboratory programs are
currently underway in stem cell and transplantation immunology. And
through ongoing clinical research, our physicians have also been
leaders in the development of national studies in:
- Acute lymphocytic leukemia
- Bone marrow transplantation
- The development of new chemotherapeutic
agents to treat cancer
Through the David Joseph Jurist Research Center, we can now give those
fighting childhood cancer and serious blood disorders the benefit of
medicine’s most promising breakthroughs at the earliest possible
stages. We’re committed to supporting further research into the
cause and treatment of these devastating diseases. And we’re
hopeful that the cure so many doctors and scientists are working toward
today will be a reality for tomorrow’s children. |
